[{"orgOrder":0,"company":"University of Zagreb","sponsor":"BioGaia Pharma","pharmaFlowCategory":"DU","therapeuticArea":"Dental and Oral Health","country":"CROATIA","productType":"Probiotic","year":"2016","type":"Inapplicable","leadProduct":"Lactobacillus Reuteri","moa":"Bacteria microbiome","graph1":"Dental and Oral Health","graph2":"Phase IV","graph3":"University of Zagreb","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Dental & Oral Health","amount2New":0,"dosageForm":"Troche\/Lozenge","sponsorNew":"University of Zagreb \/ BioGaia Pharma","highestDevelopmentStatusID":"11","companyTruncated":"University of Zagreb \/ BioGaia Pharma"},{"orgOrder":0,"company":"Haleon","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Dental and Oral Health","country":"UNITED KINGDOM","productType":"Dietary Supplement","year":"2024","type":"Inapplicable","leadProduct":"Dentifrice","moa":"Bacterial biofilm","graph1":"Dental and Oral Health","graph2":"Phase IV","graph3":"Haleon","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Dental & Oral Health","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Haleon \/ Undisclosed","highestDevelopmentStatusID":"11","companyTruncated":"Haleon \/ Undisclosed"},{"orgOrder":0,"company":"Technische Universit\u00e4t Dresden","sponsor":"Gaba International","pharmaFlowCategory":"DU","therapeuticArea":"Dental and Oral Health","country":"GERMANY","productType":"Undisclosed","year":"2011","type":"Inapplicable","leadProduct":"Amine Fluoride","moa":"Bacterial cell membrane","graph1":"Dental and Oral Health","graph2":"Phase IV","graph3":"Technische Universit\u00e4t Dresden","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Dental & Oral Health","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Technische Universit\u00e4t Dresden \/ Gaba International","highestDevelopmentStatusID":"11","companyTruncated":"Technische Universit\u00e4t Dresden \/ Gaba International"},{"orgOrder":0,"company":"Colgate Palmolive","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Dental and Oral Health","country":"INDIA","productType":"Miscellaneous","year":"2015","type":"Inapplicable","leadProduct":"Triclosan","moa":"Bacterial enoyl-[acyl-carrier-protein] reductase","graph1":"Dental and Oral Health","graph2":"Phase IV","graph3":"Colgate Palmolive","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Dental & Oral Health","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Colgate Palmolive \/ Undisclosed","highestDevelopmentStatusID":"11","companyTruncated":"Colgate Palmolive \/ Undisclosed"},{"orgOrder":0,"company":"Colgate Palmolive","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Dental and Oral Health","country":"INDIA","productType":"Miscellaneous","year":"2015","type":"Inapplicable","leadProduct":"Triclosan","moa":"Bacterial enoyl-[acyl-carrier-protein] reductase","graph1":"Dental and Oral Health","graph2":"Phase IV","graph3":"Colgate Palmolive","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Dental & Oral Health","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Colgate Palmolive \/ Undisclosed","highestDevelopmentStatusID":"11","companyTruncated":"Colgate Palmolive \/ Undisclosed"},{"orgOrder":0,"company":"Colgate Palmolive","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Dental and Oral Health","country":"INDIA","productType":"Miscellaneous","year":"2014","type":"Inapplicable","leadProduct":"Triclosan","moa":"Bacterial enoyl-[acyl-carrier-protein] reductase","graph1":"Dental and Oral Health","graph2":"Phase IV","graph3":"Colgate Palmolive","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Dental & Oral Health","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Colgate Palmolive \/ Undisclosed","highestDevelopmentStatusID":"11","companyTruncated":"Colgate Palmolive \/ Undisclosed"},{"orgOrder":0,"company":"GSK","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Dental and Oral Health","country":"UNITED KINGDOM","productType":"Antibiotic","year":"2014","type":"Inapplicable","leadProduct":"Amoxicillin Trihydrate","moa":"Bacterial penicillin-binding protein","graph1":"Dental and Oral Health","graph2":"Phase IV","graph3":"GSK","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Dental & Oral Health","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"GSK \/ Undisclosed","highestDevelopmentStatusID":"11","companyTruncated":"GSK \/ Undisclosed"},{"orgOrder":0,"company":"GSK","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Dental and Oral Health","country":"UNITED KINGDOM","productType":"Miscellaneous","year":"2012","type":"Inapplicable","leadProduct":"Chlorhexidine Gluconate","moa":"Cell membrane","graph1":"Dental and Oral Health","graph2":"Phase IV","graph3":"GSK","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Dental & Oral Health","amount2New":0,"dosageForm":"Gargle\/Mouthwash","sponsorNew":"GSK \/ Undisclosed","highestDevelopmentStatusID":"11","companyTruncated":"GSK \/ Undisclosed"},{"orgOrder":0,"company":"Dartmouth-Hitchcock Medical Center","sponsor":"DUSA Pharmaceuticals, Inc.","pharmaFlowCategory":"DU","therapeuticArea":"Dental and Oral Health","country":"U.S.A","productType":"Miscellaneous","year":"2015","type":"Inapplicable","leadProduct":"Aminolevulinic Acid HCl","moa":"DNA","graph1":"Dental and Oral Health","graph2":"Phase IV","graph3":"Dartmouth-Hitchcock Medical Center","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Dental & Oral Health","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Dartmouth-Hitchcock Medical Center \/ DUSA Pharmaceuticals, Inc.","highestDevelopmentStatusID":"11","companyTruncated":"Dartmouth-Hitchcock Medical Center \/ DUSA Pharmaceuticals, Inc."},{"orgOrder":0,"company":"University of Chile","sponsor":"Colgate Palmolive","pharmaFlowCategory":"DU","therapeuticArea":"Dental and Oral Health","country":"CHILE","productType":"Plant Extract\/Herbal","year":"2010","type":"Inapplicable","leadProduct":"Metronidazole","moa":"DNA","graph1":"Dental and Oral Health","graph2":"Phase IV","graph3":"University of Chile","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Dental & Oral Health","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"University of Chile \/ Colgate Palmolive","highestDevelopmentStatusID":"11","companyTruncated":"University of Chile \/ Colgate Palmolive"},{"orgOrder":0,"company":"Oral Health Centre of Expertise in Eastern Norway","sponsor":"Public Dental Service, Hedmark | Public Dental Service, Oppland | Public Dental Service, \u00d8stfold","pharmaFlowCategory":"DU","therapeuticArea":"Dental and Oral Health","country":"NORWAY","productType":"Miscellaneous","year":"2017","type":"Inapplicable","leadProduct":"Fluoride","moa":"Enamel","graph1":"Dental and Oral Health","graph2":"Phase IV","graph3":"Oral Health Centre of Expertise in Eastern Norway","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Dental & Oral Health","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Oral Health Centre of Expertise in Eastern Norway \/ Public Dental Service, Hedmark | Public Dental Service, Oppland | Public Dental Service, \u00d8stfold","highestDevelopmentStatusID":"11","companyTruncated":"Oral Health Centre of Expertise in Eastern Norway \/ Public Dental Service, Hedmark | Public Dental Service, Oppland | Public Dental Service, \u00d8stfold"},{"orgOrder":0,"company":"Universidad Iberoamericana","sponsor":"Colgate Palmolive","pharmaFlowCategory":"DU","therapeuticArea":"Dental and Oral Health","country":"MEXICO","productType":"Miscellaneous","year":"2015","type":"Inapplicable","leadProduct":"Fluoride","moa":"Enamel","graph1":"Dental and Oral Health","graph2":"Phase IV","graph3":"Universidad Iberoamericana","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Dental & Oral Health","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Universidad Iberoamericana \/ Colgate Palmolive","highestDevelopmentStatusID":"11","companyTruncated":"Universidad Iberoamericana \/ Colgate Palmolive"},{"orgOrder":0,"company":"Chhattisgarh Dental College and Research Institute","sponsor":"Baxter Healthcare Corporation","pharmaFlowCategory":"DU","therapeuticArea":"Dental and Oral Health","country":"INDIA","productType":"Undisclosed","year":"2012","type":"Inapplicable","leadProduct":"Fibrin Sealant","moa":"Fibrinogen \/ Thrombin","graph1":"Dental and Oral Health","graph2":"Phase IV","graph3":"Chhattisgarh Dental College and Research Institute","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Dental & Oral Health","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Chhattisgarh Dental College and Research Institute \/ Baxter Healthcare Corporation","highestDevelopmentStatusID":"11","companyTruncated":"Chhattisgarh Dental College and Research Institute \/ Baxter Healthcare Corporation"},{"orgOrder":0,"company":"Universiti Sains Malaysia","sponsor":"3M ESPE | SDI Limited","pharmaFlowCategory":"DU","therapeuticArea":"Dental and Oral Health","country":"MALAYSIA","productType":"Miscellaneous","year":"2023","type":"Inapplicable","leadProduct":"Sodium Fluoride","moa":"Hydroxyapatite","graph1":"Dental and Oral Health","graph2":"Phase IV","graph3":"Universiti Sains Malaysia","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Dental & Oral Health","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Universiti Sains Malaysia \/ 3M ESPE | SDI Limited","highestDevelopmentStatusID":"11","companyTruncated":"Universiti Sains Malaysia \/ 3M ESPE | SDI Limited"},{"orgOrder":0,"company":"GSK","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Dental and Oral Health","country":"UNITED KINGDOM","productType":"Miscellaneous","year":"2010","type":"Inapplicable","leadProduct":"Sodium Fluoride","moa":"Hydroxyapatite","graph1":"Dental and Oral Health","graph2":"Phase IV","graph3":"GSK","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Dental & Oral Health","amount2New":0,"dosageForm":"Paste","sponsorNew":"GSK \/ Undisclosed","highestDevelopmentStatusID":"11","companyTruncated":"GSK \/ Undisclosed"},{"orgOrder":0,"company":"GSK","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Dental and Oral Health","country":"UNITED KINGDOM","productType":"Miscellaneous","year":"2012","type":"Inapplicable","leadProduct":"Sodium Fluoride","moa":"Hydroxyapatite","graph1":"Dental and Oral Health","graph2":"Phase IV","graph3":"GSK","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Dental & Oral Health","amount2New":0,"dosageForm":"Paste","sponsorNew":"GSK \/ Undisclosed","highestDevelopmentStatusID":"11","companyTruncated":"GSK \/ Undisclosed"},{"orgOrder":0,"company":"University of Michigan","sponsor":"Dentsply International","pharmaFlowCategory":"DU","therapeuticArea":"Dental and Oral Health","country":"U.S.A","productType":"Miscellaneous","year":"2011","type":"Inapplicable","leadProduct":"Articaine Hydrochloride","moa":"Sodium channel alpha subunit","graph1":"Dental and Oral Health","graph2":"Phase IV","graph3":"University of Michigan","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Dental & Oral Health","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"University of Michigan \/ Dentsply International","highestDevelopmentStatusID":"11","companyTruncated":"University of Michigan \/ Dentsply International"},{"orgOrder":0,"company":"Chemische Fabrik Berg","sponsor":"Anfomed","pharmaFlowCategory":"DU","therapeuticArea":"Dental and Oral Health","country":"GERMANY","productType":"Miscellaneous","year":"2017","type":"Inapplicable","leadProduct":"Lidocaine Hydrochloride","moa":"Sodium channel alpha subunit","graph1":"Dental and Oral Health","graph2":"Phase IV","graph3":"Chemische Fabrik Berg","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Dental & Oral Health","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Chemische Fabrik Berg \/ Anfomed","highestDevelopmentStatusID":"11","companyTruncated":"Chemische Fabrik Berg \/ Anfomed"},{"orgOrder":0,"company":"Shanxi Zhendong Pharmacy Co., Ltd","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Dental and Oral Health","country":"CHINA","productType":"Antibiotic","year":"2019","type":"Inapplicable","leadProduct":"Levofloxacin","moa":"Topoisomerase IV | DNA gyrase","graph1":"Dental and Oral Health","graph2":"Phase IV","graph3":"Shanxi Zhendong Pharmacy Co., Ltd","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Dental & Oral Health","amount2New":0,"dosageForm":"Injection","sponsorNew":"Shanxi Zhendong Pharmacy Co., Ltd \/ Undisclosed","highestDevelopmentStatusID":"11","companyTruncated":"Shanxi Zhendong Pharmacy Co., Ltd \/ Undisclosed"},{"orgOrder":0,"company":"University of Santiago de Compostela","sponsor":"Johnson & Johnson","pharmaFlowCategory":"DU","therapeuticArea":"Dental and Oral Health","country":"SPAIN","productType":"Plant Extract\/Herbal","year":"2014","type":"Inapplicable","leadProduct":"Eucalyptol","moa":"TRPM8","graph1":"Dental and Oral Health","graph2":"Phase IV","graph3":"University of Santiago de Compostela","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Dental & Oral Health","amount2New":0,"dosageForm":"Oil","sponsorNew":"University of Santiago de Compostela \/ Johnson & Johnson","highestDevelopmentStatusID":"11","companyTruncated":"University of Santiago de Compostela \/ Johnson & Johnson"},{"orgOrder":0,"company":"University of Iowa","sponsor":"BioHorizons","pharmaFlowCategory":"DU","therapeuticArea":"Dental and Oral Health","country":"U.S.A","productType":"Miscellaneous","year":"2015","type":"Inapplicable","leadProduct":"Acellular Dermal Matrix","moa":"Undisclosed","graph1":"Dental and Oral Health","graph2":"Phase IV","graph3":"University of Iowa","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Dental & Oral Health","amount2New":0,"dosageForm":"Implant","sponsorNew":"University of Iowa \/ BioHorizons","highestDevelopmentStatusID":"11","companyTruncated":"University of Iowa \/ BioHorizons"},{"orgOrder":0,"company":"University of Texas Health Science Center at Houston","sponsor":"Confadent","pharmaFlowCategory":"DU","therapeuticArea":"Dental and Oral Health","country":"U.S.A","productType":"Miscellaneous","year":"2017","type":"Inapplicable","leadProduct":"Cetylpyridinium Chloride","moa":"Undisclosed","graph1":"Dental and Oral Health","graph2":"Phase IV","graph3":"University of Texas Health Science Center at Houston","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Dental & Oral Health","amount2New":0,"dosageForm":"Gum, Chewing","sponsorNew":"University of Texas Health Science Center at Houston \/ Confadent","highestDevelopmentStatusID":"11","companyTruncated":"University of Texas Health Science Center at Houston \/ Confadent"},{"orgOrder":0,"company":"Pierre Fabre","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Dental and Oral Health","country":"FRANCE","productType":"Undisclosed","year":"2015","type":"Inapplicable","leadProduct":"DC071","moa":"Undisclosed","graph1":"Dental and Oral Health","graph2":"Phase IV","graph3":"Pierre Fabre","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Dental & Oral Health","amount2New":0,"dosageForm":"Gargle\/Mouthwash","sponsorNew":"Pierre Fabre \/ Undisclosed","highestDevelopmentStatusID":"11","companyTruncated":"Pierre Fabre \/ Undisclosed"},{"orgOrder":0,"company":"Gaba International","sponsor":"PD Dr. Christian Heumann","pharmaFlowCategory":"DU","therapeuticArea":"Dental and Oral Health","country":"UNITED KINGDOM","productType":"Undisclosed","year":"2011","type":"Inapplicable","leadProduct":"Elmex","moa":"Undisclosed","graph1":"Dental and Oral Health","graph2":"Phase IV","graph3":"Gaba International","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Dental & Oral Health","amount2New":0,"dosageForm":"Gel","sponsorNew":"Gaba International \/ PD Dr. Christian Heumann","highestDevelopmentStatusID":"11","companyTruncated":"Gaba International \/ PD Dr. Christian Heumann"},{"orgOrder":0,"company":"Grupo de Investiga\u00e7\u00e3o em Bioqu\u00edmica","sponsor":"University of Lisbon | Portuguese Institute of Rheumatology | Dentaid","pharmaFlowCategory":"DU","therapeuticArea":"Dental and Oral Health","country":"BRAZIL","productType":"Miscellaneous","year":"2018","type":"Inapplicable","leadProduct":"Malic Acid","moa":"Undisclosed","graph1":"Dental and Oral Health","graph2":"Phase IV","graph3":"Grupo de Investiga\u00e7\u00e3o em Bioqu\u00edmica","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Dental & Oral Health","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Grupo de Investiga\u00e7\u00e3o em Bioqu\u00edmica \/ University of Lisbon | Portuguese Institute of Rheumatology | Dentaid","highestDevelopmentStatusID":"11","companyTruncated":"Grupo de Investiga\u00e7\u00e3o em Bioqu\u00edmica \/ University of Lisbon | Portuguese Institute of Rheumatology | Dentaid"},{"orgOrder":0,"company":"McGuire Institute","sponsor":"CellTherX","pharmaFlowCategory":"DU","therapeuticArea":"Dental and Oral Health","country":"U.S.A","productType":"Microorganism","year":"2020","type":"Inapplicable","leadProduct":"Markman Biologics Microsurfaced Adm","moa":"Undisclosed","graph1":"Dental and Oral Health","graph2":"Phase IV","graph3":"McGuire Institute","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Dental & Oral Health","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"McGuire Institute \/ CellTherX","highestDevelopmentStatusID":"11","companyTruncated":"McGuire Institute \/ CellTherX"},{"orgOrder":0,"company":"GSK","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Dental and Oral Health","country":"UNITED KINGDOM","productType":"Undisclosed","year":"2019","type":"Inapplicable","leadProduct":"Sensodyne Repair And Protect","moa":"Undisclosed","graph1":"Dental and Oral Health","graph2":"Phase IV","graph3":"GSK","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Dental & Oral Health","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"GSK \/ Undisclosed","highestDevelopmentStatusID":"11","companyTruncated":"GSK \/ Undisclosed"},{"orgOrder":0,"company":"Hayat Pharma","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Dental and Oral Health","country":"JORDAN","productType":"Undisclosed","year":"2015","type":"Inapplicable","leadProduct":"Serodase","moa":"Undisclosed","graph1":"Dental and Oral Health","graph2":"Phase IV","graph3":"Hayat Pharma","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Dental & Oral Health","amount2New":0,"dosageForm":"Tablet","sponsorNew":"Hayat Pharma \/ Undisclosed","highestDevelopmentStatusID":"11","companyTruncated":"Hayat Pharma \/ Undisclosed"},{"orgOrder":0,"company":"Colgate Palmolive","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Dental and Oral Health","country":"INDIA","productType":"Miscellaneous","year":"2025","type":"Inapplicable","leadProduct":"Fluorophosphate","moa":"Undisclosed","graph1":"Dental and Oral Health","graph2":"Phase IV","graph3":"Colgate Palmolive","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Dental & Oral Health","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Colgate Palmolive \/ Undisclosed","highestDevelopmentStatusID":"11","companyTruncated":"Colgate Palmolive \/ Undisclosed"},{"orgOrder":0,"company":"Colgate Palmolive","sponsor":"Mahidol University","pharmaFlowCategory":"DU","therapeuticArea":"Dental and Oral Health","country":"INDIA","productType":"Miscellaneous","year":"2014","type":"Inapplicable","leadProduct":"Tin Fluoride","moa":"Undisclosed","graph1":"Dental and Oral Health","graph2":"Phase IV","graph3":"Colgate Palmolive","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Dental & Oral Health","amount2New":0,"dosageForm":"Paste","sponsorNew":"Colgate Palmolive \/ Mahidol University","highestDevelopmentStatusID":"11","companyTruncated":"Colgate Palmolive \/ Mahidol University"},{"orgOrder":0,"company":"Colgate Palmolive","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Dental and Oral Health","country":"INDIA","productType":"Miscellaneous","year":"2019","type":"Inapplicable","leadProduct":"Tin Fluoride","moa":"Undisclosed","graph1":"Dental and Oral Health","graph2":"Phase IV","graph3":"Colgate Palmolive","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Dental & Oral Health","amount2New":0,"dosageForm":"Paste","sponsorNew":"Colgate Palmolive \/ Undisclosed","highestDevelopmentStatusID":"11","companyTruncated":"Colgate Palmolive \/ Undisclosed"},{"orgOrder":0,"company":"Colgate Palmolive","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Dental and Oral Health","country":"INDIA","productType":"Miscellaneous","year":"2023","type":"Inapplicable","leadProduct":"Tin Fluoride","moa":"Undisclosed","graph1":"Dental and Oral Health","graph2":"Phase IV","graph3":"Colgate Palmolive","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Dental & Oral Health","amount2New":0,"dosageForm":"Paste","sponsorNew":"Colgate Palmolive \/ Undisclosed","highestDevelopmentStatusID":"11","companyTruncated":"Colgate Palmolive \/ Undisclosed"},{"orgOrder":0,"company":"Colgate Palmolive","sponsor":"University of Texas Health Science Center at Houston","pharmaFlowCategory":"DU","therapeuticArea":"Dental and Oral Health","country":"INDIA","productType":"Miscellaneous","year":"2025","type":"Inapplicable","leadProduct":"Tin Fluoride","moa":"Undisclosed","graph1":"Dental and Oral Health","graph2":"Phase IV","graph3":"Colgate Palmolive","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Dental & Oral Health","amount2New":0,"dosageForm":"Paste","sponsorNew":"Colgate Palmolive \/ University of Texas Health Science Center at Houston","highestDevelopmentStatusID":"11","companyTruncated":"Colgate Palmolive \/ University of Texas Health Science Center at Houston"},{"orgOrder":0,"company":"Colgate Palmolive","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Dental and Oral Health","country":"INDIA","productType":"Miscellaneous","year":"2019","type":"Inapplicable","leadProduct":"Tin Fluoride","moa":"Undisclosed","graph1":"Dental and Oral Health","graph2":"Phase IV","graph3":"Colgate Palmolive","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Dental & Oral Health","amount2New":0,"dosageForm":"Paste","sponsorNew":"Colgate Palmolive \/ Undisclosed","highestDevelopmentStatusID":"11","companyTruncated":"Colgate Palmolive \/ Undisclosed"},{"orgOrder":0,"company":"Colgate Palmolive","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Dental and Oral Health","country":"INDIA","productType":"Miscellaneous","year":"2024","type":"Inapplicable","leadProduct":"Tin Fluoride","moa":"Undisclosed","graph1":"Dental and Oral Health","graph2":"Phase IV","graph3":"Colgate Palmolive","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Dental & Oral Health","amount2New":0,"dosageForm":"Paste","sponsorNew":"Colgate Palmolive \/ Undisclosed","highestDevelopmentStatusID":"11","companyTruncated":"Colgate Palmolive \/ Undisclosed"},{"orgOrder":0,"company":"Colgate Palmolive","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Dental and Oral Health","country":"INDIA","productType":"Miscellaneous","year":"2024","type":"Inapplicable","leadProduct":"Tin Fluoride","moa":"Undisclosed","graph1":"Dental and Oral Health","graph2":"Phase IV","graph3":"Colgate Palmolive","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Dental & Oral Health","amount2New":0,"dosageForm":"Paste","sponsorNew":"Colgate Palmolive \/ Undisclosed","highestDevelopmentStatusID":"11","companyTruncated":"Colgate Palmolive \/ Undisclosed"},{"orgOrder":0,"company":"PROCTER AND GAMBLE","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Dental and Oral Health","country":"U.S.A","productType":"Miscellaneous","year":"2012","type":"Inapplicable","leadProduct":"Tin Fluoride","moa":"Undisclosed","graph1":"Dental and Oral Health","graph2":"Phase IV","graph3":"PROCTER AND GAMBLE","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Dental & Oral Health","amount2New":0,"dosageForm":"Paste","sponsorNew":"PROCTER AND GAMBLE \/ Undisclosed","highestDevelopmentStatusID":"11","companyTruncated":"PROCTER AND GAMBLE \/ Undisclosed"},{"orgOrder":0,"company":"PROCTER AND GAMBLE","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Dental and Oral Health","country":"U.S.A","productType":"Miscellaneous","year":"2022","type":"Inapplicable","leadProduct":"Tin Fluoride","moa":"Undisclosed","graph1":"Dental and Oral Health","graph2":"Phase IV","graph3":"PROCTER AND GAMBLE","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Dental & Oral Health","amount2New":0,"dosageForm":"Paste","sponsorNew":"PROCTER AND GAMBLE \/ Undisclosed","highestDevelopmentStatusID":"11","companyTruncated":"PROCTER AND GAMBLE \/ Undisclosed"},{"orgOrder":0,"company":"PROCTER AND GAMBLE","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Dental and Oral Health","country":"U.S.A","productType":"Miscellaneous","year":"2023","type":"Inapplicable","leadProduct":"Tin Fluoride","moa":"Undisclosed","graph1":"Dental and Oral Health","graph2":"Phase IV","graph3":"PROCTER AND GAMBLE","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Dental & Oral Health","amount2New":0,"dosageForm":"Paste","sponsorNew":"PROCTER AND GAMBLE \/ Undisclosed","highestDevelopmentStatusID":"11","companyTruncated":"PROCTER AND GAMBLE \/ Undisclosed"},{"orgOrder":0,"company":"PROCTER AND GAMBLE","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Dental and Oral Health","country":"U.S.A","productType":"Miscellaneous","year":"2023","type":"Inapplicable","leadProduct":"Tin Fluoride","moa":"Undisclosed","graph1":"Dental and Oral Health","graph2":"Phase IV","graph3":"PROCTER AND GAMBLE","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Dental & Oral Health","amount2New":0,"dosageForm":"Paste","sponsorNew":"PROCTER AND GAMBLE \/ Undisclosed","highestDevelopmentStatusID":"11","companyTruncated":"PROCTER AND GAMBLE \/ Undisclosed"},{"orgOrder":0,"company":"PROCTER AND GAMBLE","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Dental and Oral Health","country":"U.S.A","productType":"Miscellaneous","year":"2023","type":"Inapplicable","leadProduct":"Tin Fluoride","moa":"Undisclosed","graph1":"Dental and Oral Health","graph2":"Phase IV","graph3":"PROCTER AND GAMBLE","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Dental & Oral Health","amount2New":0,"dosageForm":"Paste","sponsorNew":"PROCTER AND GAMBLE \/ Undisclosed","highestDevelopmentStatusID":"11","companyTruncated":"PROCTER AND GAMBLE \/ Undisclosed"},{"orgOrder":0,"company":"PROCTER AND GAMBLE","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Dental and Oral Health","country":"U.S.A","productType":"Miscellaneous","year":"2023","type":"Inapplicable","leadProduct":"Tin Fluoride","moa":"Undisclosed","graph1":"Dental and Oral Health","graph2":"Phase IV","graph3":"PROCTER AND GAMBLE","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Dental & Oral Health","amount2New":0,"dosageForm":"Paste","sponsorNew":"PROCTER AND GAMBLE \/ Undisclosed","highestDevelopmentStatusID":"11","companyTruncated":"PROCTER AND GAMBLE \/ Undisclosed"},{"orgOrder":0,"company":"PROCTER AND GAMBLE","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Dental and Oral Health","country":"U.S.A","productType":"Miscellaneous","year":"2021","type":"Inapplicable","leadProduct":"Tin Fluoride","moa":"Undisclosed","graph1":"Dental and Oral Health","graph2":"Phase IV","graph3":"PROCTER AND GAMBLE","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Dental & Oral Health","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"PROCTER AND GAMBLE \/ Undisclosed","highestDevelopmentStatusID":"11","companyTruncated":"PROCTER AND GAMBLE \/ Undisclosed"},{"orgOrder":0,"company":"Nova Scotia Health Authority","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Dental and Oral Health","country":"CANADA","productType":"Undisclosed","year":"2021","type":"Inapplicable","leadProduct":"Trichloroacetic Acid","moa":"Undisclosed","graph1":"Dental and Oral Health","graph2":"Phase IV","graph3":"Nova Scotia Health Authority","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Dental & Oral Health","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Nova Scotia Health Authority \/ Undisclosed","highestDevelopmentStatusID":"11","companyTruncated":"Nova Scotia Health Authority \/ Undisclosed"},{"orgOrder":0,"company":"University of Nebraska","sponsor":"3M Company","pharmaFlowCategory":"DU","therapeuticArea":"Dental and Oral Health","country":"U.S.A","productType":"Miscellaneous","year":"2018","type":"Inapplicable","leadProduct":"Vanish XT","moa":"Undisclosed","graph1":"Dental and Oral Health","graph2":"Phase IV","graph3":"University of Nebraska","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Dental & Oral Health","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"University of Nebraska \/ 3M Company","highestDevelopmentStatusID":"11","companyTruncated":"University of Nebraska \/ 3M Company"},{"orgOrder":0,"company":"GSK","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Dental and Oral Health","country":"UNITED KINGDOM","productType":"Miscellaneous","year":"2010","type":"Inapplicable","leadProduct":"Paracetamol","moa":"Vanilloid receptor | Anandamide amidohydrolase | Cyclooxygenase","graph1":"Dental and Oral Health","graph2":"Phase IV","graph3":"GSK","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Dental & Oral Health","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"GSK \/ Undisclosed","highestDevelopmentStatusID":"11","companyTruncated":"GSK \/ Undisclosed"},{"orgOrder":0,"company":"GSK","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Dental and Oral Health","country":"UNITED KINGDOM","productType":"Miscellaneous","year":"2010","type":"Inapplicable","leadProduct":"Paracetamol","moa":"Vanilloid receptor | Anandamide amidohydrolase | Cyclooxygenase","graph1":"Dental and Oral Health","graph2":"Phase IV","graph3":"GSK","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Dental & Oral Health","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"GSK \/ Undisclosed","highestDevelopmentStatusID":"11","companyTruncated":"GSK \/ Undisclosed"},{"orgOrder":0,"company":"PROCTER AND GAMBLE","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Dental and Oral Health","country":"U.S.A","productType":"Undisclosed","year":"2019","type":"Inapplicable","leadProduct":"Undisclosed","moa":"Undisclosed","graph1":"Dental and Oral Health","graph2":"Phase IV","graph3":"PROCTER AND GAMBLE","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Dental & Oral Health","amount2New":0,"dosageForm":"Paste","sponsorNew":"PROCTER AND GAMBLE \/ Undisclosed","highestDevelopmentStatusID":"11","companyTruncated":"PROCTER AND GAMBLE \/ Undisclosed"},{"orgOrder":0,"company":"PROCTER AND GAMBLE","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Dental and Oral Health","country":"U.S.A","productType":"Undisclosed","year":"2019","type":"Inapplicable","leadProduct":"Undisclosed","moa":"Undisclosed","graph1":"Dental and Oral Health","graph2":"Phase IV","graph3":"PROCTER AND GAMBLE","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Dental & Oral Health","amount2New":0,"dosageForm":"Paste","sponsorNew":"PROCTER AND GAMBLE \/ Undisclosed","highestDevelopmentStatusID":"11","companyTruncated":"PROCTER AND GAMBLE \/ Undisclosed"},{"orgOrder":0,"company":"University of Campinas, Brazil","sponsor":"Colgate Palmolive","pharmaFlowCategory":"DU","therapeuticArea":"Dental and Oral Health","country":"BRAZIL","productType":"Undisclosed","year":"2015","type":"Inapplicable","leadProduct":"Undisclosed","moa":"Undisclosed","graph1":"Dental and Oral Health","graph2":"Phase IV","graph3":"University of Campinas, Brazil","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Dental & Oral Health","amount2New":0,"dosageForm":"Paste","sponsorNew":"University of Campinas, Brazil \/ Colgate Palmolive","highestDevelopmentStatusID":"11","companyTruncated":"University of Campinas, Brazil \/ Colgate Palmolive"},{"orgOrder":0,"company":"Gustavo Avila-Ortiz","sponsor":"Osteogenics","pharmaFlowCategory":"DU","therapeuticArea":"Dental and Oral Health","country":"","productType":"Undisclosed","year":"2016","type":"Inapplicable","leadProduct":"Undisclosed","moa":"Undisclosed","graph1":"Dental and Oral Health","graph2":"Phase IV","graph3":"Gustavo Avila-Ortiz","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Dental & Oral Health","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Gustavo Avila-Ortiz \/ Osteogenics","highestDevelopmentStatusID":"11","companyTruncated":"Gustavo Avila-Ortiz \/ Osteogenics"},{"orgOrder":0,"company":"PROCTER AND GAMBLE","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Dental and Oral Health","country":"U.S.A","productType":"Miscellaneous","year":"2025","type":"Inapplicable","leadProduct":"Tin Fluoride","moa":"Undisclosed","graph1":"Dental and Oral Health","graph2":"Phase IV","graph3":"PROCTER AND GAMBLE","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Dental & Oral Health","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"PROCTER AND GAMBLE \/ Undisclosed","highestDevelopmentStatusID":"11","companyTruncated":"PROCTER AND GAMBLE \/ Undisclosed"}]

Find Clinical Drug Development Pipelines & Deals | PipelineProspector

Xls
Filters Filter
×
FILTER:
filter
Company Name
    filter

    Year

      filter

      DEALS // DEV.

        filter

        Country

          filter
          Sponsor
            filter

            Therapeutic Area

              filter

              Study Phase

                filter

                Deal Type

                  filter

                  Product Type

                    filter

                    Dosage Form

                      filter

                      Lead Product

                        filter

                        Target

                          Loading...

                          Therapeutic Area by Lead Product

                          Study Phase by Lead Product

                          Company by Lead Product

                          Top Deals by Deal Size (USD bn)

                          01

                          Details : Lidocaine HCl is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Periodontitis.

                          Product Name : Undisclosed

                          Product Type : Miscellaneous

                          Upfront Cash : Inapplicable

                          November 27, 2017

                          Lead Product(s) : Lidocaine Hydrochloride

                          Therapeutic Area : Dental and Oral Health

                          Highest Development Status : Phase IV

                          Sponsor : Anfomed

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          Moehs Chemische Fabrik Berg

                          02

                          ACI Convention
                          Not Confirmed
                          ACI Convention
                          Not Confirmed

                          Details : Stannous Fluoride is a Small Molecule drug candidate drug candidate, which is currently being evaluated in Phase IV clinical studies for the treatment of Gingivitis.

                          Product Name : Undisclosed

                          Product Type : Miscellaneous

                          Upfront Cash : Inapplicable

                          September 05, 2025

                          Lead Product(s) : Tin Fluoride

                          Therapeutic Area : Dental and Oral Health

                          Highest Development Status : Phase IV

                          Sponsor : Undisclosed

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          03

                          ACI Convention
                          Not Confirmed
                          ACI Convention
                          Not Confirmed

                          Details : Sodium Monofluorophosphate is a Vitamins/Minerals/Inorganic Salts drug candidate, which is currently being evaluated in Phase IV clinical studies for the treatment of Dental Plaque.

                          Product Name : Undisclosed

                          Product Type : Miscellaneous

                          Upfront Cash : Inapplicable

                          June 19, 2025

                          Lead Product(s) : Fluorophosphate

                          Therapeutic Area : Dental and Oral Health

                          Highest Development Status : Phase IV

                          Sponsor : Undisclosed

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          04

                          ACI Convention
                          Not Confirmed
                          ACI Convention
                          Not Confirmed

                          Details : Stannous Fluoride is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Gingivitis.

                          Product Name : Undisclosed

                          Product Type : Miscellaneous

                          Upfront Cash : Inapplicable

                          May 12, 2025

                          Lead Product(s) : Tin Fluoride

                          Therapeutic Area : Dental and Oral Health

                          Highest Development Status : Phase IV

                          Sponsor : University of Texas Health Science Center at Houston

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          05

                          ACI Convention
                          Not Confirmed
                          ACI Convention
                          Not Confirmed

                          Details : Dentifrice is a Dietary Supplement drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Dentin Sensitivity.

                          Product Name : Undisclosed

                          Product Type : Dietary Supplement

                          Upfront Cash : Inapplicable

                          September 23, 2024

                          Lead Product(s) : Dentifrice

                          Therapeutic Area : Dental and Oral Health

                          Highest Development Status : Phase IV

                          Sponsor : Undisclosed

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          06

                          Universiti Sains Malaysia

                          Country arrow
                          ACI Convention
                          Not Confirmed

                          Universiti Sains Malaysia

                          Country arrow
                          ACI Convention
                          Not Confirmed

                          Details : Sodium fluoride is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Dental Caries.

                          Product Name : Undisclosed

                          Product Type : Miscellaneous

                          Upfront Cash : Inapplicable

                          March 16, 2023

                          Lead Product(s) : Sodium Fluoride

                          Therapeutic Area : Dental and Oral Health

                          Highest Development Status : Phase IV

                          Sponsor : 3M ESPE | SDI Limited

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          07

                          ACI Convention
                          Not Confirmed
                          ACI Convention
                          Not Confirmed

                          Details : Stannous Fluoride is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Gingivitis.

                          Product Name : Undisclosed

                          Product Type : Miscellaneous

                          Upfront Cash : Inapplicable

                          February 16, 2023

                          Lead Product(s) : Tin Fluoride

                          Therapeutic Area : Dental and Oral Health

                          Highest Development Status : Phase IV

                          Sponsor : Undisclosed

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          08

                          ACI Convention
                          Not Confirmed
                          ACI Convention
                          Not Confirmed

                          Details : Stannous Fluoride is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Dental Caries.

                          Product Name : Undisclosed

                          Product Type : Miscellaneous

                          Upfront Cash : Inapplicable

                          February 21, 2021

                          Lead Product(s) : Tin Fluoride

                          Therapeutic Area : Dental and Oral Health

                          Highest Development Status : Phase IV

                          Sponsor : Undisclosed

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          09

                          ACI Convention
                          Not Confirmed
                          ACI Convention
                          Not Confirmed

                          Details : TCA is a drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Cheilitis.

                          Product Name : Undisclosed

                          Product Type : Undisclosed

                          Upfront Cash : Inapplicable

                          February 08, 2021

                          Lead Product(s) : Trichloroacetic Acid

                          Therapeutic Area : Dental and Oral Health

                          Highest Development Status : Phase IV

                          Sponsor : Undisclosed

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank

                          10

                          McGuire Institute

                          Country arrow
                          ACI Convention
                          Not Confirmed

                          McGuire Institute

                          Country arrow
                          ACI Convention
                          Not Confirmed

                          Details : Markman Biologics Microsurfaced Adm is a Microorganism drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Gingival Recession.

                          Product Name : Undisclosed

                          Product Type : Microorganism

                          Upfront Cash : Inapplicable

                          November 04, 2020

                          Lead Product(s) : Markman Biologics Microsurfaced Adm

                          Therapeutic Area : Dental and Oral Health

                          Highest Development Status : Phase IV

                          Sponsor : CellTherX

                          Deal Size : Inapplicable

                          Deal Type : Inapplicable

                          blank